Design and Rationale of the OPTIMA Study: Retreatment or Step-Up Therapy with Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU). (2018). SKIN The Journal of Cutaneous Medicine, 2(S1), S51. https://doi.org/10.25251/skin.2.supp.51